Both intravenous (IV) and intramuscular (IM) administration of the monoclonal antibody tixagevimab/cilgavimab rapidly eliminated culturable SARS-CoV-2, with both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results